This study revealed that the non-viral piggyBac transposon system-engineered EGFR-CAR T-cell therapy is feasible and safe in treatment of EGFR-positive advanced NSCLC patients [60]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.